Nexium Control 28 Tablet Pack

Nexium Control 28 Tablet Pack shot

NEW - Improved value & convenience for patients with recurrent frequent heartburn

The new Nexium Control pack size, 28 tablets, offers benefits for patients who have used esomeprazole with positive results:

  • Improved value at a lower cost per tablet
  • Product available on hand for future episodes
Flowchart of frequent and occasional heartburn

How to recommend the NEW 28 tablet pack size for Nexium Control

  • One tablet per day
  • Maximum 14 consecutive days use
  • If symptoms do not resolve or get worse after 14 days refer to a GP

*Should symptoms recur after 3 months, patients may restart a further treatment course. If less than three months after previous treatment, it is advisory to refer patients to seek advice from a GP1

Read more

Understanding frequency is key to an appropriate recommendation

  • Ask patients how often they suffer – more than once a week is classed as frequent heartburn
  • Patients with frequent heartburn may benefit from a PPI such as Nexium Control to give the oesophagus a ‘holiday’ from acid and reduce sensitivity

Learn more about the role of frequency in heartburn treatment recommendations.

Recommend Nexium Control to patients with heartburn more than once per week

Nexium Control 28 tablet pack

Nexium Control 28 tablet pack

For patients with recurrent frequent heartburn who have used esomeprazole successfully and seek the value and convenience of a larger pack.

Nexium Control 7 and 14 tablet packs

Nexium Control 7 and 14 tablet packs

Nexium Control 7 tablet pack is an ideal trial pack with one-week supply. Nexium Control 14 tablet pack offers the same protection and offers a 2-week treatment course.

Nexium Control 14 Capsule pack

Nexium Control 14 Capsule pack

Easy-to swallow mini capsules – 53% smaller than tablet* in a portable bottle. Complete 14-day treatment course.

*based on volume

Nexium Control Product Information

  • Product Information

    Product Information: Please consult the Summary of Product Characteristics for full product information. Nexium Control 20 mg gastro resistant tablets and hard capsules (esomeprazole). Indications: The short term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults. Dosage: The recommended dose is 20 mg esomeprazole (one tablet or capsule) per day. Tablets or capsules may need to be taken for 2-3 consecutive days to achieve symptom improvement. Maximum treatment duration: up to 2 weeks. Contraindications: Hypersensitivity to the active substance, substituted benzimidazoles or to any of the excipients. Esomeprazole must not be used concomitantly with nelfinavir. Precautions: Refer to doctor if patient has: Jaundice or severe liver disease, unintentional weight loss, recurrent vomiting, dysphagia, haematemesis or melaena and when gastric ulcer is suspected or present, malignancy should be excluded as treatment with esomeprazole may alleviate symptoms and delay diagnosis, gastric ulcer or gastrointestinal surgery, continuous treatment of indigestion or heartburn for 4 or more weeks, or is over 55 years old with new or recently changed symptoms. Not suitable for long term use. Treatment with proton pump inhibitors (PPIs) may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter and in hospitalised patients, also possibly Clostridium difficile. Consult doctor prior to have an endoscopy or urea breath test. Co administration with atazanavir is not recommended. Interactions with medicinal products metabolised through CYP2C19 should be considered. The use of esomeprazole with clopidogrel should be discouraged. Patients should not take another PPI or H2 antagonist concomitantly. PPI are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly. Side effects: Common: headache, abdominal pain, constipation, diarrhoea, flatulence, nausea/ vomiting, fundic gland polyps (benign). Uncommon: peripheral oedema, insomnia, dizziness, paraesthesia, somnolence, vertigo, dry mouth, increased liver enzymes, dermatitis, pruritus, rash urticaria. For rare, very rare and other side effects please refer to the SPC for full information. Legal category: Supply through pharmacy only. Product licence number: EU/1/13/860/001; EU/1/13/860/002; EU/1/13/860/003; EU/1/13/860/004 and EU/1/13/860/005. MAH: GlaxoSmithKline Dungarvan Limited, Knockbrack, Dungarvan, County Waterford, Ireland. Additional information is available upon request. Text prepared: June 2022.

    Contains esomeprazole. Always read the label/leaflet.

Nexium Control – Ireland’s No 1 pharmacy only 24-hour heartburn protection treatment2

Icon of stomach

Overview of frequent heartburn

Find out more about frequent heartburn including a profile of a patient who may suffer from the condition.

Find out more

Signup icon

Sign up for updates

For news, updates and more, click the link below to sign up and be on our mailing list

Register now

Book icon

Educational resources

Access educational resources to support your team’s understanding of heartburn and its management.

Find out more